Published on the 8th May 2014 by ANSTO Staff
The Hon Ian Macfarlane MP has overseen progress of the $168 million ANM project at ANSTO which will benefit the Australian health industry and position Australia as a global leader in the high-end manufacturing of nuclear medicine.
ANSTO CEO, Dr Adi Paterson, welcomed Minister Macfarlane back to ANSTO and reiterated the Australian leadership being demonstrated through ANSTO expanding its important medical role and helping to meet world demand for vital nuclear medicine supplies. “By investing in this new facility, the Australian Government has positioned Australia as a global leader in the manufacture of nuclear medicines,” said Mr Macfarlane. The ANM Project includes a nuclear medicine manufacturing plant and a waste treatment plant to treat by-products for permanent, safe storage at a national waste repository. The project is worth $168.8 million and subject to required approvals the plant will be operational from 2016. |